SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-014679
Filing Date
2024-04-15
Accepted
2024-04-15 17:27:38
Documents
73
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1230847
2 ex10-1.htm EX-10.1 17384
3 ex10-2.htm EX-10.2 1765
4 ex31-1.htm EX-31.1 11329
5 ex31-2.htm EX-31.2 11324
6 ex32-1.htm EX-32.1 4678
7 ex32-2.htm EX-32.2 4674
8 ex10-2_001.jpg GRAPHIC 294000
9 ex10-2_002.jpg GRAPHIC 104885
  Complete submission text file 0001493152-24-014679.txt   7187153

Data Files

Seq Description Document Type Size
10 XBRL SCHEMA FILE ocea-20230930.xsd EX-101.SCH 63010
11 XBRL CALCULATION FILE ocea-20230930_cal.xml EX-101.CAL 48272
12 XBRL DEFINITION FILE ocea-20230930_def.xml EX-101.DEF 291072
13 XBRL LABEL FILE ocea-20230930_lab.xml EX-101.LAB 416922
14 XBRL PRESENTATION FILE ocea-20230930_pre.xml EX-101.PRE 342949
76 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1041622
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Ocean Biomedical, Inc. (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40793 | Film No.: 24845574
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)